• Cosmos Health projected Fort18 to add more than $3.2 million in annual U.S. revenue within 12-18 months under its current commercialization strategy and internal assumptions.
• Forecast based on assumptions for pricing, expected sales volumes, repeat purchase behavior, distribution growth.
• Staged rollout planned to start with direct-to-consumer e-commerce, with expansion into selected retail channels over time; commercial launch targeted for June 2026.
• Product targets U.S. men’s sexual health supplement market; Grand View Research estimated U.S. market at $965.8 million in 2023, forecast to reach $1.93 billion by 2030.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202605111425ACCESSWRNAPR_____1165776) on May 11, 2026, and is solely responsible for the information contained therein.